Published in Medical Letter on the CDC and FDA, August 16th, 1999
Walter M.R. Oelemann and colleagues working in Brazil evaluated a line immunoassay (INNO-LIA Chagas Ab [INNO-LIA], Innogenetics N.V., Ghent, Belgium) for the serologic confirmation of Chagas' disease ("A Recombinant Peptide Antigen Line Immunoassay Optimized for the Confirmation of Chagas' Disease," Transfusion, July 1999;39(7):711-717).
The immunoassay combines relevant, immunodominant recombinant and synthetic antigens on a single nylon...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.